Have a personal or library account? Click to login
Aerosolized Plus Intravenous Polymyxin B Versus Colistin in the Treatment of Pandrug-Resistant Klebsiella Pneumonia-mediated Ventilator-Associated Pneumonia: A Retrospective Cohort Study in Bangladesh Cover

Aerosolized Plus Intravenous Polymyxin B Versus Colistin in the Treatment of Pandrug-Resistant Klebsiella Pneumonia-mediated Ventilator-Associated Pneumonia: A Retrospective Cohort Study in Bangladesh

The Journal of Critical Care Medicine
Volume 9 (2023): Issue 2 (April 2023)
By: Md Jahidul Hasan,  Chandra Datta Sumi,  Shihan Mahmud Redwanul Huq,  Ahmad Mursel Anam and  Raihan Rabbani  
Open Access
|May 2023

Authors

Md Jahidul Hasan

jahidrj@gmail.com

University of New South Wales, Sydney, Australia

Chandra Datta Sumi

The University of Queensland, Brisbane, Australia

Shihan Mahmud Redwanul Huq

Internal Medicine and ICU, Square Hospitals Ltd., Dhaka, Bangladesh

Ahmad Mursel Anam

High Dependency Unit, Square Hospitals Ltd., Dhaka, Bangladesh

Raihan Rabbani

Internal Medicine and ICU, Square Hospitals Ltd., Dhaka, Bangladesh
DOI: https://doi.org/10.2478/jccm-2023-0012 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Journal RSS Feed
Language: English
Page range: 106 - 115
Submitted on: Oct 10, 2022
|
Accepted on: Apr 12, 2023
|
Published on: May 8, 2023
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
polymyxin B,
colistin,
intravenous,
aerosolization,
Klebsiella pneumoniae,
ventilator-associated pneumonia
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Surgery,
Surgery, other,
Anaesthesiology,
Emergency medicine and intensive-care medicine

© 2023 Md Jahidul Hasan, Chandra Datta Sumi, Shihan Mahmud Redwanul Huq, Ahmad Mursel Anam, Raihan Rabbani, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 9 (2023): Issue 2 (April 2023)Next article